DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0018213 | Graves Disease | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0085669 | Acute leukemia | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0007107 | Malignant neoplasm of larynx | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0030319 | Panic Disorder | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0010054 | Coronary Arteriosclerosis | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0010068 | Coronary heart disease | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0004763 | Barrett Esophagus | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0007113 | Rectal Carcinoma | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0345905 | Intrahepatic Cholangiocarcinoma | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0022593 | Keratosis | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0279651 | Gallbladder adenocarcinoma | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0035934 | Rubinstein-Taybi Syndrome | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0343641 | Human papilloma virus infection | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0393574 | Huntington Disease, Late Onset | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0023895 | Liver diseases | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0026613 | Motor Skills Disorders | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C3160718 | PARKINSON DISEASE, LATE-ONSET | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0268579 | Propionic acidemia | OGG1 | 4968 | 8-oxoguanine DNA glycosylase | O15527 |
C0027051 | Myocardial Infarction | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0018889 | Helminthiasis | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0020445 | Hypercholesterolemia, Familial | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0006826 | Malignant Neoplasms | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0007138 | Carcinoma, Transitional Cell | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0677886 | Epithelial ovarian cancer | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0007097 | Carcinoma | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024